Cite
HARVARD Citation
Paz-Ares, L. et al. (n.d.). Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study. Lancet oncology. 16 (3), pp. 328-337. [Online].